Pattern: Pattern Bioscience Lands $13 Million in Funding to Develop Rapid Diagnostics Tests

Pattern Bioscience this week announced $13 million in grant and venture capital funding. The Austin-based company, formerly known as Klaris Diagnostics, plans to use the funding to develop its Digital Culture technology, a rapid bacterial identification, and susceptibility testing platform. The funding includes a $6.8 million award from CARB-X, a nonprofit based at Boston University. [...]The post Pattern Bioscience Lands $13 Million in Funding to Develop Rapid Diagnostics Tests appeared first on SiliconHills.